These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25147929)

  • 21. Simultaneous activation of mGlu
    Cieślik P; Domin H; Chocyk A; Gruca P; Litwa E; Płoska A; Radulska A; Pelikant-Małecka I; Brański P; Kalinowski L; Wierońska JM
    Neuropharmacology; 2020 Sep; 174():107866. PubMed ID: 31785263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.
    Wood MR; Noetzel MJ; Tarr JC; Rodriguez AL; Lamsal A; Chang S; Foster JJ; Smith E; Chase P; Hodder PS; Engers DW; Niswender CM; Brandon NJ; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4282-6. PubMed ID: 27476142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continued optimization of the M
    McGowan KM; Nance KD; Cho HP; Bridges TM; Conn PJ; Jones CK; Lindsley CW
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1356-1359. PubMed ID: 28237763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M
    Temple KJ; Engers JL; Long MF; Watson KJ; Chang S; Luscombe VB; Jenkins MT; Rodriguez AL; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126812. PubMed ID: 31784320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1.
    Wen W; Wang Y; Li Z; Tseng PY; McManus OB; Wu M; Li M; Lindsley CW; Dong X; Hopkins CR
    ChemMedChem; 2015 Jan; 10(1):57-61. PubMed ID: 25209672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
    Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
    J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS).
    Engers DW; Gentry PR; Williams R; Bolinger JD; Weaver CD; Menon UN; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5175-8. PubMed ID: 20667732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel allosteric effects of amiodarone at the muscarinic M5 receptor.
    Stahl E; Ellis J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M
    Long MF; Engers JL; Chang S; Zhan X; Weiner RL; Luscombe VB; Rodriguez AL; Cho HP; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2017 Nov; 27(22):4999-5001. PubMed ID: 29037946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 3-Chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor.
    Yamamoto S; Shibata T; Abe K; Oda K; Aoki T; Kawakita Y; Kawamoto H
    Chem Pharm Bull (Tokyo); 2016; 64(9):1321-37. PubMed ID: 27581637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II.
    Feng Y; Cameron MD; Frackowiak B; Griffin E; Lin L; Ruiz C; Schröter T; LoGrasso P
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2355-60. PubMed ID: 17368019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location.
    Foster DJ; Gentry PR; Lizardi-Ortiz JE; Bridges TM; Wood MR; Niswender CM; Sulzer D; Lindsley CW; Xiang Z; Conn PJ
    J Neurosci; 2014 Feb; 34(9):3253-62. PubMed ID: 24573284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of M
    Gunter BW; Gould RW; Bubser M; McGowan KM; Lindsley CW; Jones CK
    Addict Biol; 2018 Sep; 23(5):1106-1116. PubMed ID: 29044937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator.
    Hao J; Dehlinger V; Fivush AM; Rudyk HC; Britton TC; Hollinshead SP; Vokits BP; Clark BP; Henry SS; Massey SM; Peng L; Dressman BA; Heinz BA; Roberts EF; Bracey-Walker MR; Swanson S; Catlow JT; Love PL; Tepool AD; Peters SC; Simmons RM; Iyengar S; McKinzie DL; Monn JA
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1249-52. PubMed ID: 23374867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of
    Garrison AT; Orsi DL; Capstick RA; Whomble D; Li J; Carter TR; Felts AS; Vinson PN; Rodriguez AL; Han A; Hajari K; Cho HP; Teal LB; Ragland MG; Ghamari-Langroudi M; Bubser M; Chang S; Schnetz-Boutaud NC; Boutaud O; Blobaum AL; Foster DJ; Niswender CM; Conn PJ; Lindsley CW; Jones CK; Han C
    J Med Chem; 2022 Apr; 65(8):6273-6286. PubMed ID: 35417155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a potent M
    Capstick RA; Whomble D; Orsi DL; Felts AS; Rodriguez AL; Vinson PN; Chang S; Blobaum AL; Niswender CM; Conn PJ; Jones CK; Lindsley CW; Han C
    Bioorg Med Chem Lett; 2022 Nov; 76():128988. PubMed ID: 36113671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probe.
    Weaver CD; Sheffler DJ; Lewis LM; Bridges TM; Williams R; Nalywajko NT; Kennedy JP; Mulder MM; Jadhav S; Aldrich LA; Jones CK; Marlo JE; Niswender CM; Mock MM; Zheng F; Conn PJ; Lindsley CW
    Curr Top Med Chem; 2009; 9(13):1217-26. PubMed ID: 19807667
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.